R. Marino

发表

Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study

F. Rosendaal, P. Mannucci, A. Tosetto, 2022, Journal of thrombosis and haemostasis : JTH.

Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.

O. Schiraldi, V. Speciale, F. Scaraggi, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.

R. Giorgino, G. Pergola, M. Sciaraffia, 1999, Metabolism: clinical and experimental.

Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.

O. Schiraldi, F. Scaraggi, R. Marino, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.

R. Giorgino, N. Pannacciulli, G. De Pergola, 2002, Obesity research.

Pain assessment and management in Italian Haemophilia Centres.

M. Margaglione, M. Franchini, I. Nichele, 2020, Blood transfusion = Trasfusione del sangue.

Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

G. Castaman, A. Federici, E. Marchesini, 2018, Blood transfusion = Trasfusione del sangue.

Co-administration of low molecular weight heparin enhances the profibrinolytic effect of warfarin through different mechanisms.

N. Semeraro, M. Colucci, R. Marino, 2014, Thrombosis research.

Promoting physical activity in people with haemophilia: the MEMO (Movement for persons with haEMOphilia) expert consensus project.

G. Di Minno, A. Coppola, R. De Cristofaro, 2021, Blood transfusion = Trasfusione del sangue.

Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C.

O. Schiraldi, G. De Pergola, E. Cicinelli, 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long‐term prophylaxis: An expert opinion paper from an Italian panel

G. Castaman, A. Federici, E. Marchesini, 2022, European journal of haematology.

Registered nurses for the home treatment of children with haemophilia who have developed inhibitors: a case report

R. Santoro, P. Iannaccaro, R. Marino, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy

M. Margaglione, A. Tosetto, C. Santoro, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis

C. Hermans, C. Lambert, S. Mangles, 2020, Advances in Therapy.

Identification of the Profile of the Patients with Hemophilia B Eligible for Treatment with Nonacog Alfa Once-Weekly

M. Morfini, C. Santoro, R. De Cristofaro, 2020 .

Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

P. Cortesi, L. D'Angiolella, G. Di Minno, 2022, Journal of clinical medicine.

Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

M. Franchini, C. Santoro, R. Lubrano, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice

M. Napolitano, R. Marino, B. Tischer, 2018, Patient preference and adherence.

Immune tolerance induction with moroctocog‐alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high‐titre inhibitors: Data from REF.IT Registry

E. Santagostino, C. Santoro, A. Coppola, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Acquired Hemophilia A After SARS-CoV-2 Infection: A Case Report

C. Sabbà, R. Marino, G. Malcangi, 2022, Journal of medical cases.

Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.

P. Mannucci, A. Tosetto, J. Goudemand, 2021, Blood advances.

Severe venous thromboembolism in a young man with Klinefelter's syndrome and heterozygosis for both G20210A prothrombin and factor V Leiden mutations

G. De Pergola, V. Speciale, F. Scaraggi, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Assessment of the Olfactory Function in Italian Patients with Type 3 von Willebrand Disease Caused by a Homozygous 253 Kb Deletion Involving VWF and TMEM16B/ANO2

M. Margaglione, A. Menini, A. Morgan, 2015, PloS one.

High titre inhibitor to factor VIII in a haemophilia carrier

M. Margaglione, R. Marino, G. Malcangi, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding.

M. Franchini, C. Santoro, G. Castaman, 2022, Blood transfusion = Trasfusione del sangue.

Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe Hemophilia A in Italy.

Songkai Yan, A. Cicchetti, L. Stern, 2023, Journal of Medical Economics.

R. De Cristofaro, R. Santoro, E. Zanon, 2023, Mediterranean journal of hematology and infectious diseases.